| Date Filed | Type | Description |
| 08/23/2023 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 3,198 shares
@ $107.3758, valued at
$343.4k
|
|
| 06/12/2023 |
4
| ROBERTS EIRY (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 8,584 shares
@ $0
Granted 30,474 options to buy
@ $12.62, valued at
$384.6k
|
|
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/08/2023 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,121 shares
@ $105.8004, valued at
$118.6k
Sold 1,623 shares
@ $102.35, valued at
$166.1k
Sold 12,801 shares
@ $102.4075, valued at
$1.3M
Sold 980 shares
@ $104.1551, valued at
$102.1k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,623 shares
@ $80.7676, valued at
$131.1k
Sold 1,121 shares
@ $80.7975, valued at
$90.6k
Sold 980 shares
@ $79.521, valued at
$77.9k
|
|
| 02/02/2022 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 75,411 options
@ $79.02, valued at
$6M
Granted 11,074 restricted stock units
@ $0 |
|
| 01/12/2022 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,632 shares
@ $74.5014, valued at
$196.1k
|
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/29/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2020 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,257 shares
@ $90.7443, valued at
$204.8k
|
|
| 08/07/2020 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,257 shares
@ $118.8415, valued at
$268.2k
|
|
| 06/25/2020 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 5,000 shares
@ $130, valued at
$650k
Exercised 5,000 options to buy
@ $77.81, valued at
$389.1k
|
|
| 04/28/2020 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,934 shares
@ $99.4707, valued at
$192.4k
|
|
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2020 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,632 shares
@ $111.1113, valued at
$292.4k
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2019 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,857 shares
@ $84.0919, valued at
$156.2k
|
|
| 02/07/2018 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 12,250 restricted stock units
@ $0
Granted 18,400 restricted stock units
@ $0 |
|
| 01/10/2018 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 70,000 options to buy
@ $77.81, valued at
$5.4M
Granted 20,000 restricted stock units
@ $0 |
|
| 01/10/2018 |
3
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 3 on NEUROCRINE BIOSCIENCES INC |